Business Context and Reporting Period
This Form 8-K is a Current Report filed by Sunshine Heart, Inc. (not Nuwellis, Inc.) on October 13, 2015. The filing serves as a Regulation FD disclosure regarding upcoming presentations of hemodynamic data related to the Company's C-Pulse device.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the disclosure of scientific data presentations and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing announces a scheduled event rather than a change in financial condition.
Guidance, Outlook, and Management Commentary
- Upcoming Presentations: Dr. Dimitrios Georgakopoulos, Chief Scientific Officer, is scheduled to present hemodynamic data from pre-clinical studies and patients implanted with the C-Pulse device.
- Event Schedule:
- Analyst Breakfast: Tuesday, October 13, 2015, at 7:00 am PST at the W Hotel San Francisco. Presenters include Dr. Georgakopoulos, Dr. Leslie W. Miller (COUNTER-HF trial investigator), and Dr. William E. Cohn (Texas Heart Institute).
- TCT Symposium: Wednesday, October 14, 2015, where Dr. Georgakopoulos will present the same data at the Transcatheter Cardiovascular Therapeutics scientific symposium.
- Availability: Presentation materials (Exhibits 99.1, 99.2, and 99.3) are attached to the filing and will be available on the Investor section of the Sunshine Heart website following the event.
- Legal Disclaimer: The information is furnished pursuant to Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the actual content of the hemodynamic data presented in Exhibits 99.1, 99.2, and 99.3.
- Confirm the date and time of the analyst breakfast meeting (October 13, 2015, 7:00 am PST).
- Review the Company's website (ir.sunshineheart.com) for the posted presentation materials post-event.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.